Our staff is our biggest asset. Their dedication, level of education and average over 17 years of industry experience determine your project success.
With our services we optimally position our customers to maneuver in the rapidly changing biopharmaceutical markets. With accelerated timelines, early completion of the preclinical phases and robust, scalable processes we enable our customers to meet the needs of those that suffer from diseases worldwide.
Dr. Menzo Havenga
President & Chief Executive Officer
Dr. Christopher Yallop
Chief Operations and Scientific Officer
Dr. Fija Lagerwerf
Director Operations NL
Jolanda van Vliet
Director Quality Assurance & Qualified Person
Pablo Mendes de León
Head of Finance